Community priorities for programs using HIV molecular epidemiology: A best-worst scaling
Background: HIV molecular epidemiology (HIV-ME) uses genetic sequencing to study viral evolution, detect transmission clusters, and guide public health responses. Ethical, legal, and social implications of HIV-ME have been raised, yet quantitative evidence on community perspectives remains limited. We quantified community priorities for HIV-ME program features and examined their heterogeneity. Methods: Adult cisgender men who have sex with men, including people living with HIV (PLWH), were recruited from the 2023-2024 American Men’s Internet Survey. Best-worst scaling assessed the importance of 11 HIV-ME features across 11 choice tasks using a Youden experimental design. Aggregate results were estimated using conditional logit models and rescaled to importance scores summing to 100%. Heterogeneity in priorities was assessed using stratified models and latent class analysis. Results: Among 747 people who completed the survey, 18% were PLWH, 35% were under 40, 34% reported concern about stigma, and 38% resided in states with active HIV criminalization statutes. “Ensuring privacy” was the most important feature, followed by HIV-ME uses for cluster detection and response, studying viral evolution, and evaluating prevention. Priorities did not differ when stratified by HIV status (p<0.01). Two latent classes emerged: a larger “Use the Data” group (n=472, 63%) placed 64% of importance on HIV-ME uses, and a smaller ‘Protect the Data’ group (n=275, 37%) placed 26% of importance on HIV-ME uses and 64% on: ensuring privacy, obtaining permission for and providing disclosure about data use, and limiting law-enforcement access. Conclusions: Community support is broad for HIV-ME uses, particularly with protections for data privacy, access, and use.
Authors
- Anne L. R. Schuster (ORCID: https://orcid.org/0000-0003-4391-1712)
- Jeremy Sugarman (ORCID: https://orcid.org/0000-0001-7022-8332)
- Travis Sanchez (ORCID: https://orcid.org/0000-0003-1133-4762)
- John FP Bridges
- Juli Bollinger
Institutions
- Johns Hopkins University (US)
- Emory University (US)
- Johns Hopkins Medicine (US)
- The Ohio State University Wexner Medical Center (US)
- Johns Hopkins Berman Institute of Bioethics (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2026-09-24
- DOI
- https://doi.org/10.1097/qai.0000000000003962
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00